Frelinger Lab
Welcome to the Frelinger Lab
My laboratory has a number of interests united by the common theme of T cell recognition. Our main research interest has centered on novel means to characterize and enhance T cell responses to pathogens and tumors using novel methodologies. Currently we are developing new tools to deliver cytokines and determine their ability to change immune responses and perturb existing cytokine networks. We are developing a novel technology called the Protease Activated Cytokine (PACman) approach that allows for the activation of cytokines at tumor sites. The strength of this approach is its flexibility. New advances in molecular biology such as the Gibson reaction, which allows one to assemble DNA fragments seamlessly, and the availability of synthetic gene blocks coupled with phage display libraries has made it possible to develop a unique set of potential therapeutics in which the components can be manipulated in a cassette fashion. These novel reagents are not only outstanding research tools but also have the potential to be applied to patient care.
John G. Frelinger, Ph.D.
Principal Investigator
Publications
View All Publications- Instant Pot for antigen retrieval: a simple, safeĀ and economical method for use in immunohistochemistry.; BioTechniques. 2023 May 18.
- A Protease Activatable Interleukin-2 Fusion Protein Engenders Antitumor Immune Responses by Interferon Gamma-Dependent and Interferon Gamma-Independent Mechanisms.; Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research; Vol 42(7), pp. 316-328. 2022 Jul.
News
October 14, 2020
John Frelinger Co-Edits Special Issue in Frontiers in Immunology Focused on Education
September 14, 2020
John Frelinger Receives Special Commendation at URSMD Convocation
July 13, 2020
Karli Norville wins Best MBI 501 Presentation
June 10, 2020
Shannon Ferry Accepted to Dartmouth College
Contact Us
Frelinger Lab
MRBX 2-11104
601 Elmwood Ave
Rochester, NY 14642